Adher Alsayed
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Immunotherapy and Biomarkers
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Cancer Cells and Metastasis
Papers in
- Oncology 8
- Inflammatory Biomarkers in Disease Prognosis 2
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Cancer Cells and Metastasis 1
-
- Breast Cancer Treatment Studies 3
- MicroRNA in disease regulation 1
- Co-authors
- Taher Al‐Tweigeri (9 shared papers)Dahish Saed Ajarim (10 shared papers)Asma M. Tulbah (4 shared papers)Hazem Ghebeh (2 shared papers)Adnan A. Ezzat (2 shared papers)Naser B. Elkum (2 shared papers)Mohamed Alshabanah (1 shared paper)Ali Saeed Alzahrani (1 shared paper)
- Journals
- Molecular and Cellular Biology (2 papers)Journal of Clinical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Breast Care (1 paper)Scientific Reports (1 paper)
- Partner nations
- Saudi ArabiaEgyptUnited Kingdom
In The Last Decade
Adher Alsayed
16 papers receiving 367 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 107
- Oncology 154
- Internal Medicine 11
- Immunology 60
- Pulmonary and Respiratory Medicine 59
Countries citing papers authored by Adher Alsayed
This map shows the geographic impact of Adher Alsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adher Alsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adher Alsayed more than expected).
Fields of papers citing papers by Adher Alsayed
This network shows the impact of papers produced by Adher Alsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adher Alsayed. The network helps show where Adher Alsayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Adher Alsayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 92 | |
| 2 | 2024 | 48 | |
| 3 | 2018 | 47 | |
| 4 | 2009 | 40 | |
| 5 | 2022 | 29 | |
| 6 | 2020 | 27 | |
| 7 | 2021 | 18 | |
| 8 | 2014 | 17 | |
| 9 | 2015 | 16 | |
| 10 | 2017 | 14 | |
| 11 | 2000 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2024 | 2 | |
| 14 | 2021 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2006 | 0 |
About Adher Alsayed
Adher Alsayed is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Internal Medicine and Immunology, having authored 17 papers that have together received 372 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (2 papers), MicroRNA in disease regulation (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Cancer Research (107 citations), Oncology (154 citations), Internal Medicine (11 citations), Immunology (60 citations) and Pulmonary and Respiratory Medicine (59 citations). Adher Alsayed has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Taher Al‐Tweigeri, Dahish Saed Ajarim, Asma M. Tulbah, Hazem Ghebeh, Adnan A. Ezzat, Naser B. Elkum, Mohamed Alshabanah, Ali Saeed Alzahrani, Said Dermime and Abdelilah Aboussekhra. Their work appears in journals such as Molecular and Cellular Biology, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Breast Care and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.